(Total Views: 387)
Posted On: 05/20/2021 9:19:13 AM
Post# of 145247
Longhaulers phase 2 results should push up the price given the potential market. I fully expect Brazil interim results to grab us a few EUAs. With 4 doses, an easier to achieve primary endpoint against a worse SOC we should hit stat sig p value even with the smaller patient population.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)